Reported Reactions

Devices › Device types

FDA product code JJX · class 1 · Clinical Chemistry

Single (specified) analyte controls (assayed and unassayed): medical device reports filed with FDA

672 reports carry this product code, 1994–2026; 8 brands with a page.

672
reports with this product code
0% of all MAUDE reports
20
reports, 12 months to August 2026
20 in the 12 months before
92.9%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code JJX is FDA's classification for "Single (specified) analyte controls (assayed and unassayed)" (clinical Chemistry panel), a class 1 device. 672 medical device reports carry this product code, 0% of the MAUDE database, from February 1994 to July 2026.

20 reports arrived in the 12 months to August 2026, close to the 20 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.9%), injury (5.4%) and other (1%). 8 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Contour Next445330%82.4%
Contour40380%85.3%
True Metrix82730.4%65.3%
Contour Ts200%85.1%
ARCHITECT Syphilis TP1220%90.2%
Breeze2100%76.2%
Nova Max Plus Glucose Monitor100%72.8%
Truetrack100%98.4%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Ascensia Diabetes Care US45367.4%
Bayer Healthcare487.1%
Haemonetics355.2%
Mhc Medical Products121.8%
Trividia Health91.3%
Roche Diabetes Care50.7%
Nipro Diagnostics40.6%
Nova Biomedical40.6%
Abbott Point Of Care20.3%
Lifescan Europe20.3%
Abbott Germany10.1%
Lifescan10.1%
Tosoh Hi-Tec10.1%

Reports by month, five years

048Sep 2021: 1Oct 2021: 1Nov 2021: 4Dec 2021: 02022Jan 2022: 3Feb 2022: 6Mar 2022: 3Apr 2022: 3May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 1Sep 2022: 1Oct 2022: 1Nov 2022: 2Dec 2022: 42023Jan 2023: 2Feb 2023: 7Mar 2023: 0Apr 2023: 1May 2023: 0Jun 2023: 1Jul 2023: 1Aug 2023: 2Sep 2023: 3Oct 2023: 2Nov 2023: 1Dec 2023: 22024Jan 2024: 2Feb 2024: 2Mar 2024: 4Apr 2024: 2May 2024: 3Jun 2024: 2Jul 2024: 4Aug 2024: 3Sep 2024: 1Oct 2024: 4Nov 2024: 2Dec 2024: 12025Jan 2025: 1Feb 2025: 2Mar 2025: 1Apr 2025: 1May 2025: 2Jun 2025: 2Jul 2025: 2Aug 2025: 1Sep 2025: 8Oct 2025: 2Nov 2025: 0Dec 2025: 02026Jan 2026: 1Feb 2026: 2Mar 2026: 0Apr 2026: 2May 2026: 1Jun 2026: 2Jul 2026: 2Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%0
Injury5.4%36
Malfunction92.9%624
Other1%7
Not given0.7%5

Who filed

Manufacturer report97.6%656
Voluntary report1.5%10
User facility report0%0
Distributor report0%0
Not given0.9%6

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Incorrect, inadequate or imprecise result or readings33549.9%
High test results6710%
Device operates differently than expectedthe device behaved unexpectedly669.8%
Incorrect or inadequate test results487.1%
Display or visual feedback problem466.8%
Improper or incorrect procedure or method203%
Fluid/blood leak152.2%
Breakthe device broke101.5%
Leak/splashthe device leaked91.3%
Low test results91.3%
Material frayed81.2%
Nonstandard device81.2%
Use of incorrect control/treatment settings81.2%
Missing information71%
Smoking71%
High readingsreadings were too high60.9%
Output problem60.9%
Calibration problem50.7%
Device operational issue50.7%
Cut in material40.6%

Questions about single (specified) analyte controls (assayed and unassayed) reports

What is product code JJX?

FDA's classification code for "Single (specified) analyte controls (assayed and unassayed)", class 1, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.

How many reports carry this code?

672 reports through August 2026, 20 of them in the latest 12 months.

Which brands appear most often?

Contour Next (445), Contour (40), True Metrix (8), Contour Ts (2) and ARCHITECT Syphilis TP (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.